PyInvesting

Market research

002923.SHE Zhuhai Rundu Pharmaceutical Co., Ltd

SHE CNY Healthcare

Latest close

8.81 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
3B
P/E ratio
231.5
Analyst target
Not available
Dividend yield
Not available
Beta
0.0

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 7 months ago

Zhuhai Rundu Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 27.8% above its 200 day moving average.

From a valuation standpoint, the stock is 75.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.4.

Zhuhai Rundu Pharmaceutical Co., Ltd's total revenue sank by 11.1% to $303M since the same quarter in the previous year.

Its net income has increased by 69.8% to $34M since the same quarter in the previous year.

Finally, its free cash flow grew by 297.0% to $86M since the same quarter in the previous year.

Based on the above factors, Zhuhai Rundu Pharmaceutical Co., Ltd gets an overall score of 4/5.